News & Events
MSIF applies to add MS treatments on WHO’s Essential Medicines List
Working to improve access to MS treatments in low-resource settings.
Celebrating women in MS research
Inspiring messages for International Day of Women and Girls in Science
Applications for 2023 MSIF Fellowships and Grants now open
Deadline for MSIF's Grants and Fellowhips is 30 June 2023
We’re hiring! Finance Officer
MSIF are hiring a Finance Officer
€3 million to advance research in stopping MS progression
International Progressive MS Alliance invests €3 million in drug discovery project to develop therapies to stop MS…
Increasing the representativeness of patient reported outcomes
Catch up with the 2022 annual meeting on the PROMS initiative
Innovative stem cell therapy for progressive forms of MS
Results from the first clinical trial using neural stem cells to treat people with MS
Cykelnerven 2023
Conquer the highest peaks of the Tour de France to raise funds for MS!
2022 McDonald Fellowships and Du Pré Grant recipients announced
MSIF is proud to announce the recipients of the 2022 McDonald Fellowships and Du Pré Grants, from…
Pioneering proposal for a new framework to describe types of MS
Moving away from traditional clinical categories of MS may lead to better, and more personalised treatments for…
MS Expert Patient Academy launched in Central America
Strengthening smaller MS organisations with specialised training
A guide for getting older with MS
Explore our new booklet for people affected by MS: ‘Living well with MS as you grow older’